PRGO
PerrigoDNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-08-06
Current thesis
Composite grade D from latest DB weights. Momentum 29.2 / Value 55.4
Posture
Defensive
Lead driver
Value
What changed
1 setup hits (3d) with net bullish as of 2026-08-06.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
29
Value
55
Sentiment
N/A
Setup hits (3d)
1 · Net Bullish
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-08-06
Fundamentals
As of 2026-08-06 • Vendor: Data Vendor v1
Scores
As of 2026-08-06 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-08-06
Investment thesis
As of 2026-08-06
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Bullish
Target $15.33
Why
Momentum29 · Δ7d +17.2
Value55 · Δ7d +0.1
SentimentN/A · Δ7d -
So what
Weak posture (Net Bullish). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
29
21% active weight
Current posture
7d trendImproving
Δ7d
+17.2
Δ21d
+22.7
Value
55
79% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.2
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 29.2 / Value 55.4
Fundamentals (TTM)As of 2026-08-06
Fundamentals (TTM)
As of 2026-08-06
Market Cap
$1.74B
Beta
0.39
Shares Out
138.37M
P/E (TTM) · Derived
-1.2
P/S (TTM)
0.46
P/FCF (TTM)
17.35
Rev YoY
-7.2%
EPS YoY
+6080.2%
Gross Margin
+34.2%
Op Margin
+6.5%
Net Debt
$3.29B
Current Ratio
2.72
As of 2026-08-06 • Updated nightlySource: Internal modelMethodology